Drug Information
Drug General Information | Top | |||
---|---|---|---|---|
Drug ID |
D9ZEM7
|
|||
Drug Name |
HPP971
|
|||
Synonyms |
ANT 401
Click to Show/Hide
|
|||
Drug Type |
Small molecular drug
|
|||
Indication | Non-alcoholic steatohepatitis [ICD-11: DB92.1; ICD-10: K75.8; ICD-9: 571.8] | Phase 1 | [1] | |
Company |
vTv Therapeutics
|
Target and Pathway | Top | |||
---|---|---|---|---|
Target(s) | Nuclear factor erythroid 2-related factor 2 (Nrf2) | Target Info | Activator | [2] |
KEGG Pathway | Protein processing in endoplasmic reticulum | |||
NetPath Pathway | IL5 Signaling Pathway | |||
WikiPathways | Oxidative Stress | |||
Transcriptional activation by NRF2 | ||||
NRF2 pathway | ||||
Nuclear Receptors Meta-Pathway | ||||
Aryl Hydrocarbon Receptor Pathway | ||||
Mesodermal Commitment Pathway | ||||
Aryl Hydrocarbon Receptor | ||||
Quercetin and Nf-kB/ AP-1 Induced Cell Apoptosis | ||||
Arylhydrocarbon receptor (AhR) signaling pathway |
References | Top | |||
---|---|---|---|---|
REF 1 | Clinical pipeline report, company report or official report of vTv Therapeutics. | |||
REF 2 | Clinical pipeline report, company report or official report of vTv Therapeutics. |
If You Find Any Error in Data or Bug in Web Service, Please Kindly Report It to Dr. Zhou and Dr. Zhang.